Hur man uppnår optimal ångkvalitet?

Optimal ångkvalitet är en avgörande faktor i industriella processer där driftsäkerhet, energieffektivitet och produktkvalitet är viktiga faktorer. Genom att säk...

Achieve Efficient, Fast Targeting of Your Sample

Step into the future of imaging technology with VersaXRM 730.

Scale Up Your Image Analysis

ZEISS arivis Hub for accelerated analysis and faster results.

The dock that “thinks” for itself

The world of bulk material handling seems straightforward at first glance: moving, filling, delivering. However, the art of dealing with a variety of different ...

Quretech tar in 14 miljoner för utveckling av ny antibiotika

Umeåbaserade Quretech Bio har säkrat ett kapitaltillskott på 14 miljoner kronor till fortsatt utveckling av nya antibiotika och infektionbehandlingar för att bi...

Italian pharmaceutical company buys rights to immunotherapy from Sanofi

Italy's Recordati buys the rights to a treatment for the rare autoimmune disease cold agglutinin disease (CAD).

What will be the next big hype after obesity? – An expert panel highlighted their top picks

What will be the next big trend in life science? Everything from Alzheimer’s, Crispr and Omics were highlighted when the issue was debated at this year’s major ...

19 medicines in Sweden are under investigation in a major EMA inquiry

unless new evidence can be provided that they are up to standard.

Sobi announces agreement with Enable Injections

Swedish biopharma Sobi has entered into an international development and distribution agreement with US drug delivery company Enable Injections.

Xbrane backar efter ny FDA-smäll – ”Vi är mycket besvikna”

Xbrane Biopharma backar med över 30 procent på börsen efter fortsatta problem hos en kontraktstillverkare – vilket väntas leda till ytterligare förseningar av e...

The First Multi-Technology System from ZEISS

Microscope and measuring machine in one.

Företag bakom nytt potensläkemedel tar in mer finansiering

Uppsalabolaget Dicot Pharma planerar att ta in upp till 125 miljoner kronor i en företrädesemission.

LINK Medical Research

Eli Lilly skrotar smärtkandidat – ytterligare omsvängning i pipelinen

Eli Lilly lägger ner utvecklingen av sin P2X7-hämmare i fas II mot smärta. Det är den senaste förändringen i en pipeline som redan genomgått flera större omprio...

Thumbs down for lecanemab in the EU – “Very surprised”

The Azheimer's drug lecanemab has received a negative assessment from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), acc...

Study names with an attitude – more important than you might think

Ironman, T-rex, Star-Trek. Popcorn, Proper, Scout. Nope, these are neither fantasy films nor dog names. They’re the names of ongoing cancer studies in Sweden.

Mercodia AB

Kanada godkänner Leqembi – racet om alzheimerläkemedel hårdnar

Leqembi får godkännande i Kanada och stärker därmed sitt globala försprång. Läkemedlet är nu godkänt på 15 större marknader – en mer än rivalen Kisunla.

The investor: “The major common diseases are hot again”

She has previously been voted Investor of the Year and will now be moderating The Future of Swedish & Danish Life Science congress. We check the temperature of ...

Small robots to deliver pharmaceuticals to the body

Robots that can operate inside the body and a platform that combines ultrasound with AI. These are a couple of the technologies that have qualified for a list t...

Mastering Urine Microscopy: Techniques for Accurate Disease Detection

Live Webinar on September 25, 2024.

Ranking: Top 10 highest-paid CEOs in pharma

It's nice to hear that things go well for others, right? Some of those who have done really well – at least financially – are listed here in the ranking of the ...

On the hunt for high throughput diagnostics

Global diagnostics companies and laboratories are in a race against time to adapt testing capacity to current demand. Due to the global COVID 19 pandemic, the d...

MSD discontinues two Keytruda trials

MSD has stopped two late-stage trials that tested its blockbuster immunotherapy Keytruda as a treatment for skin and lung cancer.